Skip to content

ANDOCOR

Active
Public limited companyfounded 199630 yrs activeKruisblok 9, 2320 Hoogstraten, BelgiumKBO/BCE: BE 0458.952.035
Summary

ANDOCOR has been active since 1996 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4.7m and a net result of €945,405. Equity is growing by ~26.2% per year across the filed fiscal years. Its solvency ranks better than 44% of 9624 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Risk analysisWatch ReportCompare
ANDOCORActiveChecked score 96/100
Risk analysis ReportCompare

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460Manufacture of medical and dental instruments and supplies NACE 32500NACE 33102
#2 company by staff growth in Hoogstraten1 site
Size
€12.3mtotal assets 2025
Staff
39.5 FTE
Equity
€4.7m
Profit
€945,405
Turnover not published (abridged schema)
Financial health
96 Excellent Checked score 2025
Bankruptcy chance 12 m
< 0.1%
Structure
Parent
SAPKO · 99%
Board
2 members
Accounts 51 d early1 of 8 deeds read
Why 96+ Founded in 1996+ Size: 39.5 FTE, total assets €12.3m+ Liquidity: current ratio 2.18, cash €1.7m+ Profit of €945,405 (FY 2025)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Better than 72% of its sector peers (NACE 46, small)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 63+10
equity 38.2% of total assets
Liquidity 60+10
short-term debt 20.7% · cash 13.6%
Profitability 78-10
return on assets 7.7%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (4,378 companies)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%▲ +13.8% vs 11-2024 01-2025: 0.2%▲ +56.8% vs 12-2024highest value 02-2025: 0.1%▼ -69.0% vs 01-2025 03-2025: 0.1%▼ -2.8% vs 02-2025 04-2025: 0.1%● 0.0% vs 03-2025 05-2025: 0.1%● 0.0% vs 04-2025 06-2025: 0.1%● 0.0% vs 05-2025 07-2025: 0.1%● 0.0% vs 06-2025 08-2025: 0.1%● 0.0% vs 07-2025 09-2025: 0.1%● 0.0% vs 08-2025 10-2025: 0.1%▲ +14.3% vs 09-2025 11-2025: 0.1%▲ +3.8% vs 10-2025 12-2025: 0.1%▲ +9.6% vs 11-2025 01-2026: < 0.1%▼ -49.5% vs 12-2025lowest value 02-2026: < 0.1%● 0.0% vs 01-2026lowest value 03-2026: < 0.1%▲ +2.2% vs 02-2026 04-2026: < 0.1%● 0.0% vs 03-2026 05-2026: < 0.1%● 0.0% vs 04-2026 06-2026: < 0.1%● 0.0% vs 05-2026 07-2026: < 0.1%● 0.0% vs 06-2026 08-2026: < 0.1%● 0.0% vs 07-2026 09-2026: < 0.1%● 0.0% vs 08-2026 10-2026: < 0.1%▲ +2.1% vs 09-2026
  • Founded in 1996 lowers the probability for this profile
  • Size: 39.5 FTE, total assets €12.3m lowers the probability for this profile
  • Liquidity: current ratio 2.18, cash €1.7m lowers the probability
  • Profit of €945,405 (FY 2025) lowers the probability
Credit up to €450,000 at 30 days acceptable
Liquidity ample (current ratio 2.18 against 1.74 in 2024; short-term debt: 20.7% and cash: 13.6% of total assets), but 61.8% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, small). Better than this share of them on solvency 44%, liquidity 79%, profitability 78%, growth against the median 86%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 04-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Founded in 1996
In the bankruptcy model this factor lowers the probability for this profile.
KBO
lowers risk · Size: 39.5 FTE, total assets €12.3m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 2.18, cash €1.7m
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Profit of €945,405 (FY 2025)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 11-12-2025, 51 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
51 d early
2024
25 d early
2023
50 d early
2022
1 d early
2021
on the day
2020
5 d early
2019
39 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 24 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 6 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-06-2026 close05-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Reappointments: Sapko BV (non-statutory director) and…Permanent representative: Patrick Rosa
  2. Annual accounts filedfiscal year 2025 · abbreviated…
  3. Annual accounts filedfiscal year 2024 · abbreviated…

Key points

  • Positive: Among the best 5% on net resultsector median €27,379 · 9,602 companies €945,405 View
  • Caution: Result fell in 2025from €2.1m to €945,405 ▼ 54.7% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Controlled by SAPKO 99% View
  • Positive: 7 profitable years in a rowprofit 2025: €945,405 7 years View
  • New directorslatest change 06-10-2025 · 2 in office 2 joined View
  • Flemish supportawarded 2022 - 2025 €103,010 View

By topic

Financials

Fiscal year
2025
Total assets
€12.3m
Profit
€945,405
Solvency
38.2%
Total assets▼ 9.5%
Net result
20192025
Go to Financials

Timeline

Events
16
Since
2016
Next accounts
by 31-01-2027
  1. 23-02-2026Reappointments: Sapko BV (non-statutory director) and Sylvie…
  2. 11-12-2025Annual accounts filed
  3. 06-01-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
04-10-1996
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure